2023_affordability_review_summary_report_genvoya.pdf
Gilead Sciences Inc. Continues Genvoya Drug Supply and Assistance
Trusted by teams at
Description
Gilead Sciences Inc., the manufacturer of Genvoya, provided information and ongoing drug supply to Colorado patients as examined in the 2023 Affordability Review. The company's assistance programs also support patient access and affordability.
Contract Details
Vendor
GILEAD SCIENCES INC
Agency
Colorado Division of Insurance, CO
Contract Type
SUPPLIES
Document Date
February 23, 2024
Renewal Info
Gilead provides ongoing manufacturer support; no fixed term or renewal specified.
More from GILEAD SCIENCES INC
Related Contracts
City of La Verne Planning Commission Agenda Packet 2026-06-10
AMENDEDFoster City Planning Commission Agenda 2026-05-21
RECOMMENDEDCook County Health and Hospitals System Finance Committee Meeting Minutes December 2025
ONGOINGCook County Health Grant Awards and Renewals Report Dec 2025
RENEWEDjohn-h-stroger-jr-hospital-board-report-september-27-2024_ea6.pdf
APPROVEDMore from Colorado Division of Insurance
addendum_to_2023_affordability_review_summary_repo.pdf
addendum_to_2023_affordability_review_summary_repo.pdf
addendum_to_2023_affordability_review_summary_repo.pdf
addendum_to_2023_affordability_review_summary_repo.pdf
Colorado Prescription Drug Affordability Board Meeting October 2024
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.